 SAN FRANCISCO, Calif. and SUZHOU, China, Sept. 02, 2021 GLOBE NEWSWIRE -- Adagene Inc. Adagene Nasdaq: ADAG, a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagenes Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will participate in the Morgan Stanley 19th Annual Global Healthcare Conference to be held virtually September 9-15, 2021. 